Filing Flows

Filing Flows › Syndax Pharmaceuticals (SNDX) › How it makes money

How Syndax Pharmaceuticals (SNDX) makes money

Syndax Pharmaceuticals (SNDX) made $83.3M of revenue in the third quarter 2026 (Q3 2026), +82% from a year earlier. Product brought in $60.7M (73%); Collaboration Revenue brought in $22.6M (27%).

Drawing the Sankey…

Syndax Pharmaceuticals revenue by segment, Q3 2026Syndax Pharmaceuticals revenue by segment, Q3 2026Product$60.7MCollaboration Revenue$22.6M
Syndax Pharmaceuticals: revenue by line, Q2 2025 to Q3 2026Syndax Pharmaceuticals: revenue by line, Q2 2025 to Q3 2026ProductCollaboration RevenueProduct: $60.7M latest$60.7MCollaboration Revenue: $22.6M latest$22.6MQ2 2025Q3 2025Q1 2026Q2 2026Q3 2026
Product went from 75% of revenue in Q2 2025 to 73% in Q3 2026, the largest shift in the mix.
Syndax Pharmaceuticals revenue by quarterSyndax Pharmaceuticals revenue by quarter$20.0MQ1 2025$38.0MQ2 2025$45.9MQ3 2025$68.7MQ4 2025$64.9MQ1 2026$72.8MQ2 2026$83.3MQ3 2026

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Product$60.7M72.9%+11%+90%
Collaboration Revenue$22.6M27.1%+25%+63%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$83.3M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$83.3M+82%
Q2 2026$72.8M+92%
Q1 2026$64.9M+224%
Q4 2025$68.7M+795%
Q3 2025$45.9M+267%
Q2 2025$38.0M+984%
Q1 2025$20.0M—

From Syndax Pharmaceuticals' 10-Q filed Nov 2, 2026 (on EDGAR).

Questions

How does Syndax Pharmaceuticals make money?

Syndax Pharmaceuticals (SNDX) made $83.3M of revenue in the third quarter 2026 (Q3 2026), +82% from a year earlier. Product brought in $60.7M (73%); Collaboration Revenue brought in $22.6M (27%).

What is Syndax Pharmaceuticals' biggest business?

Product: $60.7M in the third quarter 2026, 73% of revenue, +90% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.